Furthermore, EBI3 blocking suppressed CRC cell proliferation through the gp130/Stat3 pathway, which mediated cell survival in various tumor, such as gastric cancer [30], breast cancer [31], hepatocellular carcinoma [32], and also CRC [33, 34]. Here, EBI3 is linked to colorectal carcinoma.